Gasporox AB (publ) OMXSTO:GPX:
RECEIVES 4.4 MSEK ORDER FOR VIALARCHTM FROM MAXCANN
Gasporox Gets SEK 4.4 Mln Order For Vialarchtm
Earlier from Gasporox
- Gasporox Q3 Net Sales At SEK 9.45 Mln
- GPX: Q2 revenue fell 29% year-over-year, but a strong order backlog supports a positive H2 outlook
- GPX: Sales declined but financing and R&D investments support future growth in quality control markets
- GPX: 9% revenue growth and new financing position Gasporox for continued global expansion
- GPX: Q3 revenue up 14% year-over-year, with positive EBITDA and strengthened equity base
Later from Gasporox
- GPX: Record Q4 sales, positive EBITDA, and strategic expansion despite lower annual revenue
- GPX: Revenue doubled and EBITDA turned positive in Q1 2026, driven by pharma and food growth
- Gasporox Appoints Jan Erik Smith As Chairman Of Board
Follow Gasporox into a list and get an email when it puts out news.
Follow Gasporox